Swiss medical device developer Debiotech SA, and Fresenius Medical Care AG & Co. have partnered to develop a portfolio of peritoneal technologies, the companies announced today.
The new product platform will offer dialysis machines that are lightweight and compact, making it more practical to dialyze at home, the companies said in news release. They said the smaller size of Fresenius Medical Care’s new generation of PD machines will provide flexibility for dialysis patients when they travel, their intuitive design will promote ease of use, and their accompanying teaching methods are intended to make it easy for patients who are new to PD to use the machines.
“We are dedicated to continuing to produce home dialysis machines that are as easy and convenient as possible for our customers to operate, because this is what they demand and deserve,” said Mark Costanzo, President, Fresenius Medical Care Renal Therapies Group. “We expect that collaborating with such an exceptional team will provide dialysis patients with generations of products that will offer them a new level of ease of use and flexibility to help them meet their goal to dialyze at home.”
The Fresenius Medical Care and Debiotech partnership is exclusive globally, with the exception of Japan, the companies said.